The blood-ocular barrier (BOB) shares similar neuroepithelial origin,
microanatomy and functions with the blood-brain barrier. There are man
y natural (e. g. diabetes, hypertension) or iatrogenic (chemotherapy,
retinal photocoagulation) conditions which can cause of BOB breakdown,
resulting in visual acuity impairment or loss. The authors examined 4
2 patients affected by BOB damage in different pathological conditions
. All patients previously underwent a conventional fluoroangiographic
(FA) study. Nine patients with normal FA exam were evaluated also. Des
pite normal MRI findings immediately after Gd-DTPA injection, contrast
leakage into the vitreous body or into the aqueous fluid was demonstr
ated in delayed scans (40-50 min after contrast administration), provi
ng the existence of a BOB damage (sensitively 94%). Although FA exam r
emains the choice modality in BOB breakdown demonstration, we propose
MRI as a useful diagnostic tool when optic media opacity (cataract, ha
emovitreous, intraocular silicon oil) occurs, preventing direct retina
l fundus imaging and/or an early screening tool.